Events

Trending on OncLive

Next-Generation CTLA-4 Targeting Frames Post-Immunotherapy Squamous NSCLC Management

Firmonertinib Fails to Meet PFS End Point in First-Line EGFR Exon 20 Insertion–Mutant NSCLC

Carotuximab Plus Apalutamide Improves PFS in mCRPC

Epcoritamab Plus R-CHOP Meets PFS End Point in Newly Diagnosed DLBCL

Dr Dhakal on the Investigation of Novel CAR T-Cell Therapy Approaches in Myeloma